Related Experiment Video
Updated: Aug 3, 2026
12:06
Direct Induction of Human Neural Stem Cells from Peripheral Blood Hematopoietic Progenitor Cells
Published on: January 28, 2015
Source of stem cell rescue: bone marrow versus peripheral blood progenitors
S F Williams1, T Zimmerman, G Grad
1Department of Medicine, University of Chicago Medical Center, IL 60637.
Journal of Hematotherapy
|January 1, 1993
Summary
Peripheral blood stem cells (PBPCs) effectively restore blood cell production after chemotherapy. Using PBPCs can shorten hospital stays and reduce the need for transfusions and antibiotics, supporting more intensive cancer treatments.
Area of Science:
- Hematology
- Oncology
- Stem Cell Transplantation
Background:
- Dose-intensive chemotherapy necessitates effective methods for restoring blood cell production (hematopoiesis).
- Peripheral blood progenitors (PBPCs) have shown promise in hematopoietic reconstitution.
- Comparing different stem cell sources is crucial for optimizing patient recovery.
Purpose of the Study:
- To review and compare data on hematopoietic recovery using various stem cell sources after dose-intensive therapy.
- To evaluate the impact of peripheral blood progenitors (PBPCs) on patient outcomes.
Main Methods:
- Review of existing literature and clinical data comparing stem cell sources for hematopoietic rescue.
- Analysis of outcomes including time to hematopoietic recovery, hospital stay duration, and transfusion/antibiotic requirements.
Main Results:
- Peripheral blood progenitors (PBPCs) alone or augmenting autologous bone marrow can accelerate hematopoietic recovery.
- Patients receiving PBPCs experienced shorter hospital stays.
- Reduced requirements for blood transfusions and antibiotic usage were observed with PBPC use.
Conclusions:
- Peripheral blood progenitors (PBPCs) are effective for hematopoietic rescue post-chemotherapy.
- The use of PBPCs can improve patient outcomes and facilitate more intensive treatment regimens.
- PBPC utilization supports the increased application of dose-intensive therapies for malignancies.
Related Concept Videos
01:21Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:34Production of Formed Elements
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...